Intermediate Filaments 2008 Gordon Research Conference
中间长丝 2008 年戈登研究会议
基本信息
- 批准号:7479953
- 负责人:
- 金额:$ 0.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-06-01 至 2009-05-31
- 项目状态:已结题
- 来源:
- 关键词:Alexander DiseaseAmyotrophic Lateral SclerosisApoptoticArchitectureBiologyCardiomyopathiesCell physiologyCellsCollaborationsCytoskeletonDefectDevelopmentDiseaseEpitheliumEukaryotaEukaryotic CellEyeFosteringFundingGene ExpressionGenesHuman GenomeIntermediate FilamentsLaminsLipodystrophyLiver diseasesMechanicsMolecularMuscleMuscle functionMuscular DystrophiesMutationNervous system structureNuclearNumbersOralOrganellesParticipantPremature aging syndromeProteinsReagentResearchRoleScheduleSignal TransductionSignaling ProteinSkinStressSystemTissuesTravelcollegekeratin 7mammalian genomeneuropathologynovelnovel strategiespolypeptideprogramsrelating to nervous systemresilienceresponsescaffoldsymposiumtool
项目摘要
DESCRIPTION (provided by applicant): This proposal is a request for funds to support travel and registration for participants in the 10th Gordon Research Conference on Intermediate Filaments, which will be held Sept 7, 2008 to Sept. 12, 2008 Magdalan College, Oxford, UK. Intermediate Filaments (IFs) are major components of the cytoskeleton and nucleoskeleton in higher eukaryotes. In the public draft of the human genome, there are 65 functional genes encoding IF-forming polypeptides. These genes are regulated in a cell-specific manner and are highly conserved in mammalian genomes. A general function of IFs is to endow cells and tissues with mechanical resilience to withstand various types of physical and non-physical stresses. Defects in IF proteins underlie a vast number of genetically determined rare and common disorders involving epithelia (e.g., skin, oral, eye and liver disorders), muscle (e.g., cardiomyopathies; muscular dystrophy), neural tissue (e.g., amyotrophic lateral sclerosis; Alexander disease), lipodystrophies, and premature aging syndromes. IF proteins fulfill other functions in a differentiation and context-dependent fashion, including the response to apoptotic signals, protein targeting to subcellular compartments, cell signaling, subcellular organelle function and nuclear architecture and gene expression. This Gordon Research Conference (GRC) represents the only regular meeting devoted to IF biology. It brings together participants of junior and senior rank from all over the world, who study IF proteins from functional, regulatory, structural, and disease-related perspectives. This GRC has traditionally fostered a free-flowing exchange of novel ideas, tools and reagents, and facilitated the establishment of productive collaborations. The Program for the 2008 edition of the Conference has been finalized and will have a major focus on the broad disease aspect of these proteins, their emerging role in cell signaling and organelle function, the enlarging list of associated proteins they interact with, new structural findings, and potential novel approaches for therapy. The specific sessions that have been scheduled are: 1) Signaling via the IF scaffolds; 2) Molecular mechanism of the cytoskeleton; 3) Lamins and lamina-associated proteins; 4) Laminopathic diseases; 5) IF systems of the nervous system; 6) Neuropathologies caused by mutations in IF proteins; 7) Keratins in development and disease; 8) Muscle function and desminopathies; 9) Factors integrating IF systems into cellular physiology.
描述(由申请人提供):本提案是一份资金申请,用于支持第10届戈登中间纤维研究会议与会者的旅行和注册,该会议将于2008年9月7日至2009年9月10日举行。12,2008年英国牛津大学马格达兰学院。中间丝是高等真核生物细胞骨架和核骨架的主要组成部分。在公开的人类基因组草图中,有65个编码IF形成多肽的功能基因。这些基因以细胞特异性方式调节,并且在哺乳动物基因组中高度保守。IF的一般功能是赋予细胞和组织机械弹性,以承受各种类型的物理和非物理应力。IF蛋白的缺陷是大量涉及上皮细胞的遗传决定的罕见和常见疾病的基础(例如,皮肤、口腔、眼睛和肝脏疾病),肌肉(例如,心肌病;肌营养不良),神经组织(例如,肌萎缩性侧索硬化;亚历山大病)、脂肪营养不良和早衰综合征。IF蛋白以分化和环境依赖的方式实现其他功能,包括对凋亡信号的响应、蛋白质靶向亚细胞区室、细胞信号传导、亚细胞器功能和核结构以及基因表达。这个戈登研究会议(GRC)是唯一一个专门讨论IF生物学的定期会议。它汇集了来自世界各地的初级和高级参与者,他们从功能,调节,结构和疾病相关的角度研究IF蛋白。传统上,该研究中心促进了新思想、工具和试剂的自由交流,并促进了富有成效的合作。2008年版的会议计划已经完成,将主要关注这些蛋白质的广泛疾病方面,它们在细胞信号传导和细胞器功能中的新作用,与它们相互作用的相关蛋白质的扩大列表,新的结构发现,以及潜在的新治疗方法。已安排的具体会议有:1)通过IF支架的信号传导; 2)细胞骨架的分子机制; 3)核纤层蛋白和核纤层相关蛋白; 4)核纤层病; 5)神经系统的IF系统; 6)IF蛋白突变引起的神经病理学; 7)角蛋白在发育和疾病中的作用; 8)肌肉功能和结蛋白病; 9)将IF系统整合到细胞生理学中的因素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS B. SHEA其他文献
THOMAS B. SHEA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS B. SHEA', 18)}}的其他基金
Is S-adenosyl Methionine a Nutrition: Genetic Link in AD?
S-腺苷甲硫氨酸是一种营养:AD 中的遗传联系吗?
- 批准号:
7257368 - 财政年份:2007
- 资助金额:
$ 0.5万 - 项目类别:
Is S-adenosyl Methionine a Nutrition: Genetic Link in AD?
S-腺苷甲硫氨酸是一种营养:AD 中的遗传联系吗?
- 批准号:
7385896 - 财政年份:2007
- 资助金额:
$ 0.5万 - 项目类别:
Nanospheres as Vehicles for Treatment of Neuroblastoma
纳米球作为治疗神经母细胞瘤的载体
- 批准号:
6710556 - 财政年份:2004
- 资助金额:
$ 0.5万 - 项目类别:
CONCURRENT TRETINOIN AND CHEMOTHERAPY WITH OR WITHOUT ARSENIC TRIOXIDE
维生素A酸与化疗同时使用或不使用三氧化二砷
- 批准号:
7200202 - 财政年份:2004
- 资助金额:
$ 0.5万 - 项目类别:
Concurrent Tretinoin and Chemotherapy With or Without Arsenic Trioxide
联合维A酸和化疗联合或不联合三氧化二砷
- 批准号:
6980628 - 财政年份:2003
- 资助金额:
$ 0.5万 - 项目类别:
HOW DO NEURONS REPLACE VIMENTIN WITH NEUROFILAMENTS?
神经元如何用神经丝取代波形蛋白?
- 批准号:
2889447 - 财政年份:1998
- 资助金额:
$ 0.5万 - 项目类别:
HOW DO NEURONS REPLACE VIMENTIN WITH NEUROFILAMENTS?
神经元如何用神经丝取代波形蛋白?
- 批准号:
2693300 - 财政年份:1998
- 资助金额:
$ 0.5万 - 项目类别:
CALPAIN/KINASE RELATIONSHIPS IN NEURONAL INJURY AND DEGENERATION
神经元损伤和退化中钙蛋白酶/激酶的关系
- 批准号:
6098450 - 财政年份:1998
- 资助金额:
$ 0.5万 - 项目类别:
CALPAIN/KINASE RELATIONSHIPS IN NEURONAL INJURY AND DEGENERATION
神经元损伤和退化中钙蛋白酶/激酶的关系
- 批准号:
6234416 - 财政年份:1997
- 资助金额:
$ 0.5万 - 项目类别:
EXACERBATION OF AD NEUROPATHOLOGY BY ASTROGLIAL FACTORS
星形胶质细胞因素加剧 AD 神经病理学
- 批准号:
2054951 - 财政年份:1994
- 资助金额:
$ 0.5万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Standard Grant
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Fellowship